Daniel Alkon - NextTrip President Chief Scientific Officer
| NTRP Stock | USD 2.77 0.20 6.73% |
President
Dr. Daniel Alkon, M.D., serves as President, Chief Scientific Officer of the Company. Dr. Alkon was the founding Scientific Director of BRNI since 1999. He received his undergraduate degree in chemistry in 1965 at the University of Pennsylvania. After earning his M.D. at Cornell University and finishing an internship in medicine at the Mount Sinai Hospital in New York, he joined the staff of the National Institutes of Health where during his 30 year career he became a Medical Director in the U.S. Public Health Service at the National Institute of Neurological Disorders and Strokes and Chief of the Laboratory of Adaptive Systems since 2016.
| Age | 72 |
| Tenure | 8 years |
| Address | 1560 Sawgrass Corporate Parkway, Sunrise, FL, United States, 33323 |
| Phone | 888 444 5555 |
| Web | https://www.nexttrip.com |
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Daniel Peale | Gartner | 43 | |
| John Symington | Fiserv Inc | 63 | |
| Henry Schweppe | ExlService Holdings | 51 | |
| Larry Solomon | EPAM Systems | 55 | |
| Kendall Davis | Gartner | 50 | |
| Jules Kaufman | Gartner | 62 | |
| Aimee Arana | Digimarc | 40 | |
| Victor Guaglianone | Genpact Limited | 61 | |
| Michael Diliberto | Gartner | 58 | |
| Albert Weisner | Wavedancer | N/A | |
| Remberto Villa | ExlService Holdings | 60 | |
| Piyush Mehta | Genpact Limited | 55 | |
| Kathryn Stein | Genpact Limited | 46 | |
| Vikas Bhalla | ExlService Holdings | 52 | |
| Nagaraja Srivatsan | ExlService Holdings | 51 | |
| Charles Bunce | Wavedancer | N/A | |
| WingDar Ker | VNET Group DRC | 63 | |
| Steven Russell | Fiserv Inc | 56 | |
| Robin Kranich | Gartner | 53 | |
| Nigel Lakey | Fiserv Inc | 65 | |
| Steve Russell | Fiserv Inc | 49 | |
NextTrip Leadership Team
Elected by the shareholders, the NextTrip's board of directors comprises two types of representatives: NextTrip inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NextTrip. The board's role is to monitor NextTrip's management team and ensure that shareholders' interests are well served. NextTrip's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NextTrip's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jonathan Schechter, Director | ||
| Bruce Bernstein, Director | ||
| David Crockford, VP of Regulatory Affairs of Neurotrope Bioscience | ||
| Amy Proost, Chief Officer | ||
| Joshua Silverman, Chairman of the Board | ||
| Michael Ciraolo, COO, General Counsel | ||
| Kenneth Gorelick, Director | ||
| Andrew Perlman, Director | ||
| Susanne Wilke, Director | ||
| William Kerby, CEO Founder | ||
| William Singer, Secretary, Director | ||
| Paula Trzepacz, Executive Vice President and Chief Medical Officer | ||
| James Gottlieb, Director | ||
| Elaine Grenier, Director of Clinical Operations of Neurotrope Bioscience | ||
| Rama Marupilla, Chief Officer | ||
| Paul Freiman, Chairman of the Board | ||
| Daniel Alkon, President Chief Scientific Officer | ||
| Gregory CPA, Chief Officer | ||
| Ivan Gergel, Director | ||
| Charles Ramat, CEO and President and Director | ||
| Richard Marshall, Director Development | ||
| Jay Haft, Director | ||
| Shana Phares, Director | ||
| Lyndsey North, President | ||
| Larry Altstiel, Director | ||
| Robert Weinstein, CFO, Executive VP, Treasurer and Secretary | ||
| Charles Ryan, Director |
NextTrip Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NextTrip a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Price To Earning | (1.55) X | ||||
| Revenue | 630.43 K | ||||
| EBITDA | (8.55 M) | ||||
| Net Income | (8.69 M) | ||||
| Cash And Equivalents | 27 M | ||||
| Cash Per Share | 1.13 X | ||||
| Debt To Equity | (546.81) % | ||||
| Current Ratio | 22.40 X | ||||
| Book Value Per Share | 1.17 X | ||||
| Cash Flow From Operations | (8.21 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NextTrip in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NextTrip's short interest history, or implied volatility extrapolated from NextTrip options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NextTrip. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in NextTrip Stock, please use our How to Invest in NextTrip guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for NextTrip Stock analysis
When running NextTrip's price analysis, check to measure NextTrip's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextTrip is operating at the current time. Most of NextTrip's value examination focuses on studying past and present price action to predict the probability of NextTrip's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextTrip's price. Additionally, you may evaluate how the addition of NextTrip to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is NextTrip's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NextTrip. If investors know NextTrip will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NextTrip listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NextTrip is measured differently than its book value, which is the value of NextTrip that is recorded on the company's balance sheet. Investors also form their own opinion of NextTrip's value that differs from its market value or its book value, called intrinsic value, which is NextTrip's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NextTrip's market value can be influenced by many factors that don't directly affect NextTrip's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NextTrip's value and its price as these two are different measures arrived at by different means. Investors typically determine if NextTrip is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NextTrip's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.